(Q38074861)

28 August 2017

1 reference

title

Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand (English)

1 reference

28 August 2017

0 references

Nor Saadah M Azahri

1

1 reference

28 August 2017

Mary M Kavurma

series ordinal

2

1 reference

28 August 2017

publication date

18 January 2013

1 reference

Cellular and Molecular Life Sciences

28 August 2017

published in

1 reference

28 August 2017

volume

70

1 reference

28 August 2017

issue

19

1 reference

28 August 2017

page(s)

3617-3629

1 reference

Identification and characterization of a new member of the TNF family that induces apoptosis

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Metalloproteinase 2 cleaves in vitro recombinant TRAIL: potential implications for the decreased serum levels of TRAIL after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

A novel receptor for Apo2L/TRAIL contains a truncated death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Expression, regulation and function of trail in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL signalling: decisions between life and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Is TRAIL the holy grail of cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Genomic organization and transcriptional regulation of human Apo2/TRAIL gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL-beta and TRAIL-gamma: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Novel transcript variants of TRAIL show different activities in activation of NF-κB and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Isolation and molecular characterization of the 5'-upstream region of the human TRAIL gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL promotes VSMC proliferation and neointima formation in a FGF-2-, Sp1 phosphorylation-, and NFkappaB-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappaB and induction of insulin-like growth factor-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: mechanisms of PDGF-BB-mediated VSMC proliferation and migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Egr-1 target genes in human endothelial cells identified by microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Forkhead transcription factors are targets of signalling by the proto-oncogene PKB (C-AKT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Signaling through the JAK/STAT pathway, recent advances and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

IRF family of transcription factors as regulators of host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Sp1-mediated TRAIL induction in chemosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

TRAIL regulates normal erythroid maturation through an ERK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Following TRAIL's path in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Elevated serum TRAIL levels in scleroderma patients and its possible association with pulmonary involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Preliminary clinical measurement of the expression of TNF-related apoptosis inducing ligand in patients with ankylosing spondylitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Tumor necrosis factor (TNF) and phorbol ester induce TNF-related apoptosis-inducing ligand (TRAIL) under critical involvement of NF-kappa B essential modulator (NEMO)/IKKgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Formyl peptide receptor-like 1 mediated endogenous TRAIL gene expression with tumoricidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Identification of TRAIL as an interferon regulatory factor 3 transcriptional target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Caspase 3 activation is essential for efficient influenza virus propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

A potential role for the nuclear factor of activated T cells family of transcriptional regulatory proteins in adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

NFATc1 regulation of TRAIL expression in human intestinal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Caspase-8 in cancer biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1264-X

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

21 January 2018

1 reference

12 December 2020

Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage

1 reference

12 December 2020

Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.

1 reference

12 December 2020

Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies

1 reference

12 December 2020

TRAIL expression up-regulated by interferon-gamma via phosphorylation of STAT1 induces myeloma cell death

1 reference

12 December 2020

TRAIL Promotes the Survival and Proliferation of Primary Human Vascular Endothelial Cells by Activating the Akt and ERK Pathways

1 reference

12 December 2020

TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells

1 reference

12 December 2020

Egr-1-induced endothelial gene expression: a common theme in vascular injury

1 reference

12 December 2020

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects

1 reference

12 December 2020

Human T cell leukemia virus-I (HTLV-I) Tax-mediated apoptosis in activated T cells requires an enhanced intracellular prooxidant state

1 reference

12 December 2020

EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors

1 reference

12 December 2020

Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative

1 reference

12 December 2020

Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta

1 reference

12 December 2020

Systemic Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery Shows Antiatherosclerotic Activity in Apolipoprotein E–Null Diabetic Mice

1 reference

12 December 2020

Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis.

1 reference

12 December 2020

10.1007/S00018-013-1264-X

Identifiers

DOI

1 reference

28 August 2017

1 reference